Cargando…

Atypical IκB proteins – nuclear modulators of NF-κB signaling

Nuclear factor κB (NF-κB) controls a multitude of physiological processes such as cell differentiation, cytokine expression, survival and proliferation. Since NF-κB governs embryogenesis, tissue homeostasis and the functions of innate and adaptive immune cells it represents one of the most important...

Descripción completa

Detalles Bibliográficos
Autores principales: Schuster, Marc, Annemann, Michaela, Plaza-Sirvent, Carlos, Schmitz, Ingo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639191/
https://www.ncbi.nlm.nih.gov/pubmed/23578005
http://dx.doi.org/10.1186/1478-811X-11-23
_version_ 1782475914738663424
author Schuster, Marc
Annemann, Michaela
Plaza-Sirvent, Carlos
Schmitz, Ingo
author_facet Schuster, Marc
Annemann, Michaela
Plaza-Sirvent, Carlos
Schmitz, Ingo
author_sort Schuster, Marc
collection PubMed
description Nuclear factor κB (NF-κB) controls a multitude of physiological processes such as cell differentiation, cytokine expression, survival and proliferation. Since NF-κB governs embryogenesis, tissue homeostasis and the functions of innate and adaptive immune cells it represents one of the most important and versatile signaling networks known. Its activity is regulated via the inhibitors of NF-κB signaling, the IκB proteins. Classical IκBs, like the prototypical protein IκBα, sequester NF-κB transcription factors in the cytoplasm by masking of their nuclear localization signals (NLS). Thus, binding of NF-κB to the DNA is inhibited. The accessibility of the NLS is controlled via the degradation of IκBα. Phosphorylation of the conserved serine residues 32 and 36 leads to polyubiquitination and subsequent proteasomal degradation. This process marks the central event of canonical NF-κB activation. Once their NLS is accessible, NF-κB transcription factors translocate into the nucleus, bind to the DNA and regulate the transcription of their respective target genes. Several studies described a distinct group of atypical IκB proteins, referred to as the BCL-3 subfamily. Those atypical IκBs show entirely different sub-cellular localizations, activation kinetics and an unexpected functional diversity. First of all, their interaction with NF-κB transcription factors takes place in the nucleus in contrast to classical IκBs, whose binding to NF-κB predominantly occurs in the cytoplasm. Secondly, atypical IκBs are strongly induced after NF-κB activation, for example by LPS and IL-1β stimulation or triggering of B cell and T cell antigen receptors, but are not degraded in the first place like their conventional relatives. Finally, the interaction of atypical IκBs with DNA-associated NF-κB transcription factors can further enhance or diminish their transcriptional activity. Thus, they do not exclusively act as inhibitors of NF-κB activity. The capacity to modulate NF-κB transcription either positively or negatively, represents their most important and unique mechanistic difference to classical IκBs. Several reports revealed the importance of atypical IκB proteins for immune homeostasis and the severe consequences following their loss of function. This review summarizes insights into the physiological processes regulated by this protein class and the relevance of atypical IκB functioning.
format Online
Article
Text
id pubmed-3639191
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36391912013-04-30 Atypical IκB proteins – nuclear modulators of NF-κB signaling Schuster, Marc Annemann, Michaela Plaza-Sirvent, Carlos Schmitz, Ingo Cell Commun Signal Review Nuclear factor κB (NF-κB) controls a multitude of physiological processes such as cell differentiation, cytokine expression, survival and proliferation. Since NF-κB governs embryogenesis, tissue homeostasis and the functions of innate and adaptive immune cells it represents one of the most important and versatile signaling networks known. Its activity is regulated via the inhibitors of NF-κB signaling, the IκB proteins. Classical IκBs, like the prototypical protein IκBα, sequester NF-κB transcription factors in the cytoplasm by masking of their nuclear localization signals (NLS). Thus, binding of NF-κB to the DNA is inhibited. The accessibility of the NLS is controlled via the degradation of IκBα. Phosphorylation of the conserved serine residues 32 and 36 leads to polyubiquitination and subsequent proteasomal degradation. This process marks the central event of canonical NF-κB activation. Once their NLS is accessible, NF-κB transcription factors translocate into the nucleus, bind to the DNA and regulate the transcription of their respective target genes. Several studies described a distinct group of atypical IκB proteins, referred to as the BCL-3 subfamily. Those atypical IκBs show entirely different sub-cellular localizations, activation kinetics and an unexpected functional diversity. First of all, their interaction with NF-κB transcription factors takes place in the nucleus in contrast to classical IκBs, whose binding to NF-κB predominantly occurs in the cytoplasm. Secondly, atypical IκBs are strongly induced after NF-κB activation, for example by LPS and IL-1β stimulation or triggering of B cell and T cell antigen receptors, but are not degraded in the first place like their conventional relatives. Finally, the interaction of atypical IκBs with DNA-associated NF-κB transcription factors can further enhance or diminish their transcriptional activity. Thus, they do not exclusively act as inhibitors of NF-κB activity. The capacity to modulate NF-κB transcription either positively or negatively, represents their most important and unique mechanistic difference to classical IκBs. Several reports revealed the importance of atypical IκB proteins for immune homeostasis and the severe consequences following their loss of function. This review summarizes insights into the physiological processes regulated by this protein class and the relevance of atypical IκB functioning. BioMed Central 2013-04-11 /pmc/articles/PMC3639191/ /pubmed/23578005 http://dx.doi.org/10.1186/1478-811X-11-23 Text en Copyright © 2013 Schuster et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Schuster, Marc
Annemann, Michaela
Plaza-Sirvent, Carlos
Schmitz, Ingo
Atypical IκB proteins – nuclear modulators of NF-κB signaling
title Atypical IκB proteins – nuclear modulators of NF-κB signaling
title_full Atypical IκB proteins – nuclear modulators of NF-κB signaling
title_fullStr Atypical IκB proteins – nuclear modulators of NF-κB signaling
title_full_unstemmed Atypical IκB proteins – nuclear modulators of NF-κB signaling
title_short Atypical IκB proteins – nuclear modulators of NF-κB signaling
title_sort atypical iκb proteins – nuclear modulators of nf-κb signaling
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639191/
https://www.ncbi.nlm.nih.gov/pubmed/23578005
http://dx.doi.org/10.1186/1478-811X-11-23
work_keys_str_mv AT schustermarc atypicalikbproteinsnuclearmodulatorsofnfkbsignaling
AT annemannmichaela atypicalikbproteinsnuclearmodulatorsofnfkbsignaling
AT plazasirventcarlos atypicalikbproteinsnuclearmodulatorsofnfkbsignaling
AT schmitzingo atypicalikbproteinsnuclearmodulatorsofnfkbsignaling